Electronic Platform for Diabetic Patients Activation

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana106 enrolled

Overview

The purpose of this study is to assess the efficacy of an electronic platform for doctor-patient communication in order to reduce severe and non-severe hypoglycemia events as well as inadvertent hypoglycemia events.

This is an open randomized clinical trial without drugs. Patients with type 2 diabetes and treated with insulin will be included. Patients allocated in the intervention group will use the electronic platform as a communication channel with their health provider during the time between visits. The name of the platform is ti.care (https://ti.care/es) and it will be a complement of the control visits to resolve doubts through chats, email or video call. Health providers will answer the patient requests.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

106

Conditions

Hypoglycemia Hypoglycemia Acute

Interventions

ti.careDEVICE

Electronic platform for doctor-patient communication

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Aged over 17 years * Patients with type 2 diabetes diagnosis * Patients who start insulin treatment or with intensification of treatment * Patients who sign informed consent Exclusion Criteria: * Patients with type 1 diabetes diagnosis * Life expectancy less than one year * Pregnancy * Patients with dementia * Patients with treatment different to insulin * Patients who, in the opinion of the researcher, cannot follow the recommendations of the self-care health education plan.

Outcomes

Primary Outcomes

Change from HbA1c level at 3 months

Time frame: Baseline and at 3 months

Change from basal capillary blood glucose at 3 months

Time frame: Baseline and at 3 months

Change from postprandial blood glucose at 3 months

Time frame: Baseline and at 3 months

Change from nocturnal blood glucose at 3 months

Time frame: Baseline and at 3 months

Total hypoglycemia

Number of total hypoglycemia events

Time frame: At 3 months

Number of nocturnal hypoglycemia events

Time frame: At 3 months

Number of inadvertent hypoglycemia events

Time frame: At 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.